Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 29, 2026 09:00 ET | Source: Wetour Robotics Limited

Wetour Robotics Regains Compliance with Nasdaq Minimum Bid Price Requirement; Matter Closed

Compliance regained within the original 180-day period and without a share consolidation as the Company continues to focus on Orchestra Physical AI commercial execution. Austin, TX, June 29, 2026 ...
June 29, 2026 08:44 ET | Source: Polyrizon Ltd.

Polyrizon Makes Strong Progress: Receives Central IRB Approval for its Allergy Blocker Clinical Trial

Raanana, Israel, June 29, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative...
June 29, 2026 08:32 ET | Source: Rider Levett Bucknall

RLB North America Releases Q2 2026 Construction Cost Report

Phoenix, AZ, June 29, 2026 (GLOBE NEWSWIRE) -- Rider Levett Bucknall (RLB) has released its second quarter 2026 Quarterly Construction Cost Report (QCR), highlighting a period of strategic alignment...
June 29, 2026 08:30 ET | Source: Aqua-Tots Swim Schools

Aqua-Tots Shares Five Water Safety Tips for a Safer Fourth of July

Phoenix, Arizona, June 29, 2026 (GLOBE NEWSWIRE) -- As Americans prepare to celebrate the 250th anniversary of the United States, Aqua-Tots Swim School is encouraging families to add one more item...
June 29, 2026 08:30 ET | Source: Oncotelic Therapeutics, Inc.

Oncotelic Announces Peer-Reviewed Validation of Deciparticle™ Platform Supporting Clinical Development of Sapu003

Publication Highlights Novel Intravenous Everolimus Formulation and Demonstrates Broad Potential of Deciparticle™ Technology for Hydrophobic Therapeutics SAN DIEGO, Calif., June 29, 2026 (GLOBE...
June 29, 2026 08:30 ET | Source: Palisade Bio, Inc.

Palisade Bio Receives FDA Clearance of IND for PALI-2108 and Plans to Initiate Global Phase 2 ASCENTRA-UC Study in Ulcerative Colitis

ASCENTRA-UC expected to enroll up to 204 patients with moderately to severely active ulcerative colitis across North America and Europe First patient enrollment anticipated in the second half of...
June 29, 2026 08:30 ET | Source: SNS Insider pvt ltd

Quantum Computing in Drug Discovery Market Size to Reach USD 1.48 Billion by 2035 | SNS Insider

Austin, United States, June 29, 2026 (GLOBE NEWSWIRE) -- The Quantum Computing in Drug Discovery Market Size was valued at USD 0.45 Billion in 2025 and is projected to reach USD 1.48 Billion by...
June 29, 2026 08:30 ET | Source: Biodexa Pharmaceuticals PLC

Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress

June 29, 2026 Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAPandUpdate on Serenta Progress Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) (“Biodexa” or “the Company”),...
June 29, 2026 08:30 ET | Source: Quantum Cyber

Quantum Cyber Signs Definitive Agreements to Acquire U.S.-Based Manufacturing Facility in Bridgeport, Connecticut

WEST PALM BEACH, Florida, June 29, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (Nasdaq: QUCY) (“Quantum Cyber” or the “Company”), a Nasdaq-listed autonomous defense technology company assembling an...
June 29, 2026 08:30 ET | Source: Mingteng International Corporation Inc.

Mingteng International Reaches New Milestone in Global Expansion with Overseas Orders Serving Markets in Serbia, Vietnam and Mexico

Wuxi, China, June 29, 2026 (GLOBE NEWSWIRE) -- Mingteng International Corporation Inc. (the “Company” or “Mingteng International”) (Nasdaq: MTEN), an automotive mold developer and supplier in...